Mutant Huntingtin Causes a Selective Decrease in the Expression of Synaptic Vesicle Protein 2C

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Hsu, S. M., Raine, L., & Fanger, H. (1981) · Journal of Histochemistry & Cytochemistry · doi:10.1177/29.4.6166661 · Cited by 14,248 · see citing works

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes

MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366 · see citing works

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055 · see citing works

Huntington's disease

Walker, F. O. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60111-1 · Cited by 2,623 · see citing works

Correlation of mRNA and protein in complex biological samples

Maier, T., Güell, M., & Serrano, L. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.10.036 · Cited by 1,802 · see citing works

Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin [published erratum appears in Hum Mol Genet 1999 May;8(5):943]

Schilling, G. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.3.397 · Cited by 755 · see citing works

Relationship between differentially expressed mRNA and mRNA-protein correlations in a xenograft model system

Koussounadis, A., Langdon, S. P., Um, I. H., Harrison, D. J., & Smith, V. A. (2015) · Scientific Reports · doi:10.1038/srep10775 · Cited by 639 · see citing works

Transcriptional abnormalities in Huntington disease

Sugars, K. L., & Rubinsztein, D. C. (2003) · Trends in Genetics · doi:10.1016/s0168-9525(03)00074-x · Cited by 529 · see citing works

The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABAA receptor alterations in the human basal ganglia in Huntington's disease

Glass, M., Dragunow, M., & Faull, R. L. M. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00008-7 · Cited by 525 · see citing works

The role of the hippocampus in flexible cognition and social behavior

Rubin, R. D., Watson, P. D., Duff, M. C., & Cohen, N. J. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00742 · Cited by 489 · see citing works

Differential expression of synaptic vesicle protein 2 (SV2) isoforms

Bajjalieh, S., Frantz, G., Weimann, J., McConnell, S., & Scheller, R. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-09-05223.1994 · Cited by 440 · see citing works

Transcriptional dysregulation in Huntington’s disease

Cha, J.-H. J. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01609-x · Cited by 399 · see citing works

Integrated genomics and proteomics define huntingtin CAG length-dependent networks in mice

Langfelder, P., Cantle, J. P., Chatzopoulou, D., Wang, N., Gao, F., Al-Ramahi, I., Lu, X.-H., Ramos, E. M., El-Zein, K., Zhao, Y., et al. (2016) · Nature Neuroscience · doi:10.1038/nn.4256 · Cited by 385 · see citing works

Evidence for specific cognitive deficits in preclinical Huntington's disease

Lawrence, A. D. (1998) · Brain · doi:10.1093/brain/121.7.1329 · Cited by 382 · see citing works

Cognitive Impairment in Huntington Disease: Diagnosis and Treatment

Paulsen, J. S. (2011) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-011-0215-x · Cited by 364 · see citing works

Over the river, through the woods: cognitive maps in the hippocampus and orbitofrontal cortex

Wikenheiser, A. M., & Schoenbaum, G. M. (2016) · Nature reviews. Neuroscience · doi:10.1038/nrn.2016.56 · Cited by 353 · see citing works

Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function

Raymond, L. A., André, V. M., Cepeda, C., Gladding, C. M., Milnerwood, A. J., & Levine, M. S. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.052 · Cited by 319 · see citing works

Early synaptic pathophysiology in neurodegeneration: insights from Huntington's disease

Milnerwood, A. J., & Raymond, L. A. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2010.08.002 · Cited by 311 · see citing works

Brain imaging and cognitive dysfunctions in Huntington’s disease

Montoya, A. G., Price, B. H., Menear, M., & Lepage, M. (2006) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0603 · Cited by 265 · see citing works

Genetics and Neuropathology of Huntington's Disease

Reiner, A. J., Dragatsis, I., & Dietrich, P. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-381328-2.00014-6 · Cited by 262 · see citing works

Mutant Huntingtin Causes Context-Dependent Neurodegeneration in Mice with Huntington's Disease

Yu, Z.-X., Li, S.-H., Evans, J., Pillarisetti, A., He, L., & Li, X. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-06-02193.2003 · Cited by 260 · see citing works

Huntington's disease

Novak, M. J. U., & Tabrizi, S. J. (2010) · BMJ · doi:10.1136/bmj.c3109 · Cited by 255 · see citing works

Widespread Disruption of Repressor Element-1 Silencing Transcription Factor/Neuron-Restrictive Silencer Factor Occupancy at Its Target Genes in Huntington's Disease

Zuccato, C., Belyaev, N., Conforti, P., Ooi, L., Tartari, M., Papadimou, E., MacDonald, M., Fossale, E., Zeitlin, S., Buckley, N., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4278-06.2007 · Cited by 239 · see citing works

Animal Models of Huntington's Disease

Ramaswamy, S., McBride, J. L., & Kordower, J. H. (2007) · ILAR Journal · doi:10.1093/ilar.48.4.356 · Cited by 234 · see citing works

SV2C is a synaptic vesicle protein with an unusually restricted localization: anatomy of a synaptic vesicle protein family

Janz, R., & Südhof, T. C. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00370-x · Cited by 214 · see citing works

Huntington's disease: a synaptopathy?

Li, J., Plomann, M., & Brundin, P. (2003) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2003.08.006 · Cited by 208 · see citing works

Immunohistochemistry and Quantitative Analysis of Protein Expression

Cregger, M. A., Berger, A. J., & Rimm, D. L. (2006) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2006-130-1026-iaqaop · Cited by 201 · see citing works

Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond

Löscher, W., Gillard, M., Sands, Z. A., Kaminski, R. M., & Klitgaard, H. (2016) · CNS Drugs · doi:10.1007/s40263-016-0384-x · Cited by 184 · see citing works

Survivin Expression Quantified by Image Pro-plus Compared With Visual Assessment

Wang, C., Zhou, Z., Holmqvist, A., Zhang, H., Li, Y., Adell, G., & Sun, X. (2009) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0b013e3181a13bf2 · Cited by 172 · see citing works

Synaptic dysfunction in Huntington's disease: a new perspective

Smith, R., Brundin, P., & Li, J.-Y. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5084-5 · Cited by 166 · see citing works

Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington's disease

Wang, C.-E., Tydlacka, S., Orr, A. L., Yang, S., Graham, R. K., Hayden, M. R., Li, S., Chan, A. W. S., & Li, X.-J. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn175 · Cited by 163 · see citing works

Cooperation of the basal ganglia, cerebellum, sensory cerebrum and hippocampus: possible implications for cognition, consciousness, intelligence and creativity

COTTERILL, R. M. J. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00058-7 · Cited by 155 · see citing works

Mouse models of Huntington's disease and methodological considerations for therapeutic trials

Ferrante, R. J. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.04.001 · Cited by 150 · see citing works

Rodent genetic models of Huntington disease

Heng, M. Y., Detloff, P. J., & Albin, R. L. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.06.005 · Cited by 149 · see citing works

The external globus pallidus: progress and perspectives

Hegeman, D. J., Hong, E. S., Hernández, V. M., & Chan, C. S. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13196 · Cited by 149 · see citing works

Cortico–Basal Ganglia Circuit Function in Psychiatric Disease

Gunaydin, L. A., & Kreitzer, A. C. (2015) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105355 · Cited by 147 · see citing works

7 tesla magnetic resonance imaging: A closer look at substantia nigra anatomy in Parkinson's disease

Lehéricy, S., Bardinet, É., Poupon, C., Vidailhet, M., & François, C. (2014) · Movement Disorders · doi:10.1002/mds.26043 · Cited by 142 · see citing works

SV2 regulates neurotransmitter release via multiple mechanisms

Nowack, A., Yao, J., Custer, K. L., & Bajjalieh, S. M. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00259.2010 · Cited by 138 · see citing works

Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease

Dunn, A. R., Stout, K. A., Ozawa, M., Lohr, K. M., Hoffman, C. A., Bernstein, A. I., Li, Y., Wang, M., Sgobio, C., Sastry, N. G., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616892114 · Cited by 138 · see citing works

New roles for the external globus pallidus in basal ganglia circuits and behavior

Gittis, A. H., Berke, J. D., Bevan, M. D., Chan, C. S., Mallet, N., Morrow, M. M., & Schmidt, R. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.3252-14.2014 · Cited by 136 · see citing works

Abnormalities in the synaptic vesicle fusion machinery in Huntington’s disease

Morton, A. J., Faull, R. L. M., & Edwardson, J. M. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00611-6 · Cited by 132 · see citing works

Synaptic dysfunction and septin protein family members in neurodegenerative diseases

Marttinen, M., Kurkinen, K. M. A., Soininen, H. S., Haapasalo, A., & Hiltunen, M. O. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0013-z · Cited by 129 · see citing works

Mechanisms of synaptic dysfunction and excitotoxicity in Huntington's disease

Sepers, M. D., & Raymond, L. A. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.02.006 · Cited by 126 · see citing works

Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin A

Benoit, R., FREY, D. J., Hilbert, M., Kevenaar, J. T., Wieser, M. M., Stirnimann, C. U., McMillan, D., Ceska, T., Lebon, F., Jaussi, R., et al. (2013) · Nature · doi:10.1038/nature12732 · Cited by 126 · see citing works

Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington's disease by preventing p75^NTRup-regulation and astrocyte-mediated inflammation

Miguez, A., García-Díaz Barriga, G., Brito, V., Straccia, M., Giralt, A., Ginés, S., Canals, J. M., & Alberch, J. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv218 · Cited by 126 · see citing works

A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin

Damiano, M. G., Diguet, E., Malgorn, C., D’Aurelio, M., Galvan, L., Petit, F., Haim, L. B., Guillermier, M., Houitte, D., Dufour, N., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt242 · Cited by 124 · see citing works

SV2 Acts via Presynaptic Calcium to Regulate Neurotransmitter Release

Wan, Q.-F., Zhou, Z., Thakur, P., Vila, A., Sherry, D. M., Janz, R., & Heidelberger, R. (2010) · Neuron · doi:10.1016/j.neuron.2010.05.010 · Cited by 123 · see citing works

Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease

Lin, L., Park, J. W., Ramachandran, S. S., Zhang, Y., Tseng, Y., Shen, S., Waldvogel, H. J., Curtis, M. A., Faull, R. L. M., Troncoso, J. C., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw187 · Cited by 122 · see citing works

Neurotrophin receptor p75NTR mediates Huntington’s disease–associated synaptic and memory dysfunction

Brito, V., Giralt, A., Enriquez-Barreto, L., Puigdellívol, M., Suelves, N., Zamora-Moratalla, A., Ballesteros, J. J., Martín, E. D., Dominguez-Iturza, N., Morales, M., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74809 · Cited by 114 · see citing works

A structure-based analysis of huntingtin mutant polyglutamine aggregation and toxicity: evidence for a compact beta-sheet structure

Poirier, M. A. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi071 · Cited by 109 · see citing works

Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington’s disease

McBride, J. L., Ramaswamy, S., Gasmi, M., Bartus, R. T., Herzog, C. D., Brandon, E. P., Zhou, L., Pitzer, M. R., Berry‐Kravis, E., & Kordower, J. H. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508875103 · Cited by 106 · see citing works

Huntingtin Regulates RE1-silencing Transcription Factor/Neuron-restrictive Silencer Factor (REST/NRSF) Nuclear Trafficking Indirectly through a Complex with REST/NRSF-interacting LIM Domain Protein (RILP) and Dynactin p150Glued

Shimojo, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804183200 · Cited by 106 · see citing works

An in vitro perspective on the molecular mechanisms underlying mutant huntingtin protein toxicity

Cisbani, G., & Cicchetti, F. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.121 · Cited by 102 · see citing works

Functional connectivity and integrative properties of globus pallidus neurons

Jaeger, D., & Kita, H. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.07.050 · Cited by 100 · see citing works

Transcription, Epigenetics and Ameliorative Strategies in Huntington’s Disease: a Genome-Wide Perspective

Valor, L. M. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8715-8 · Cited by 99 · see citing works

Progressive axonal transport and synaptic protein changes correlate with behavioral and neuropathological abnormalities in the heterozygous Q175 KI mouse model of Huntington's disease

Smith, G. A., Rocha, E. M., McLean, J. R., Hayes, M. A., Izen, S. C., Ole Isacson, A., & Hallett, P. J. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu166 · Cited by 95 · see citing works

The Effects of Pharmacological Inhibition of Histone Deacetylase 3 (HDAC3) in Huntington’s Disease Mice

Jia, H., Wang, Y., Morris, C. D., Jacques, V., Gottesfeld, J. M., Rusche, J. R., & Thomas, E. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152498 · Cited by 95 · see citing works

Progressive depletion of complexin II in a transgenic mouse model of Huntington's disease

Morton, A. J., & Edwardson, J. M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00059.x · Cited by 94 · see citing works

SV2A and SV2C contain a unique synaptotagmin-binding site

Schivell, A. E., Mochida, S., Kensel-Hammes, P., Custer, K. L., & Bajjalieh, S. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.12.011 · Cited by 93 · see citing works

Striatal synaptic dysfunction and altered calcium regulation in Huntington disease

Raymond, L. A. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.07.058 · Cited by 92 · see citing works

Dysregulation of synaptic proteins, dendritic spine abnormalities and pathological plasticity of synapses as experience-dependent mediators of cognitive and psychiatric symptoms in Huntington’s disease

Nithianantharajah, J., & Hannan, A. J. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.05.043 · Cited by 91 · see citing works

Transcriptional dysregulation in Huntington's disease: a failure of adaptive transcriptional homeostasis

Kumar, A., Vaish, M., & Ratan, R. R. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.03.016 · Cited by 82 · see citing works

Studying neurodegenerative diseases in culture models

Schlachetzki, J. C. M., Saliba, S. W., & de Oliveira, A. C. P. (2013) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2013-1159 · Cited by 80 · see citing works

Mitochondrial division inhibitor 1 protects against mutant huntingtin-induced abnormal mitochondrial dynamics and neuronal damage in Huntington's disease

Mańczak, M., & Reddy, P. H. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv429 · Cited by 77 · see citing works

Dysregulation of REST ‐regulated coding and non‐coding RNA s in a cellular model of Huntington's disease

Soldati, C., Bithell, A., Johnston, C., Wong, K., Stanton, L. W., & Buckley, N. J. (2012) · Journal of Neurochemistry · doi:10.1111/jnc.12090 · Cited by 76 · see citing works

Multiple Aspects of Gene Dysregulation in Huntington’s Disease

Moumné, L., Bétuing, S., & Caboche, J. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00127 · Cited by 76 · see citing works

Exocytosis and Synaptic Vesicle Function

Shin, O. (2014) · Comprehensive physiology · doi:10.1002/cphy.c130021 · Cited by 75 · see citing works

Altered frontostriatal coupling in pre‐manifest Huntington’s disease: effects of increasing cognitive load

Wolf, R. C., Sambataro, F., Vasić, N., Schönfeldt‐Lecuona, C., Ecker, D., & Landwehrmeyer, G. B. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02253.x · Cited by 73 · see citing works

A genetic basis for the variable effect of smoking/nicotine on Parkinson’s disease

Hill-Burns, E. M., Singh, N., Ganguly, P., Hamza, T. H., Montimurro, J. S., Kay, D. M., Yearout, D., Sheehan, P., Frodey, K., McLear, J. A., et al. (2012) · The Pharmacogenomics Journal · doi:10.1038/tpj.2012.38 · Cited by 69 · see citing works

Exercise is not beneficial and may accelerate symptom onset in a mouse model of Huntington’s disease

Potter, M. C., Yuan, C., Ottenritter, C., Mughal, M. R., & van Praag, H. (2010) · PLoS Currents · doi:10.1371/currents.rrn1201 · Cited by 68 · see citing works

Expression pattern of synaptic vesicle protein 2 ( SV 2) isoforms in patients with temporal lobe epilepsy and hippocampal sclerosis

Crèvecœur, J., Kaminski, R. M., Rogister, B., Foerch, P., Vandenplas, C., Neveux, M., Mazzuferi, M., Kroonen, J., Poulet, C., Martin, D., et al. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12054 · Cited by 68 · see citing works

Onset of Huntington's disease: Can it be purely cognitive?

Paulsen, J. S., & Long, J. D. (2014) · Movement Disorders · doi:10.1002/mds.25997 · Cited by 63 · see citing works

Interrogation of brain miRNA and mRNA expression profiles reveals a molecular regulatory network that is perturbed by mutant huntingtin

Jin, J., Cheng, Y., Zhang, Y., Wood, W. H., Peng, Q., Hutchison, E. R., Mattson, M. P., Becker, K. G., & Duan, W. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07925.x · Cited by 62 · see citing works

Huntington’s Disease: From Mutant Huntingtin Protein to Neurotrophic Factor Therapy

Sari, Y. (2011) · International Journal of Biomedical Science · doi:10.59566/ijbs.2011.7089 · Cited by 62 · see citing works

p75NTR in Huntington's disease: beyond the basal ganglia

Brito, V., & Ginés, S. (2015) · Oncotarget · doi:10.18632/oncotarget.6646 · Cited by 61 · see citing works

Hippocampal dysfunction defines disease onset in Huntington's disease

Begeti, F., Schwab, L. C., Mason, S., & Barker, R. A. (2016) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-312413 · Cited by 60 · see citing works

Synaptopathic mechanisms of neurodegeneration and dementia: Insights from Huntington’s disease

Tyebji, S., & Hannan, A. J. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.03.008 · Cited by 56 · see citing works

Distribution of SV2C mRNA and protein expression in the mouse brain with a particular emphasis on the basal ganglia system

Dardou, D., Dassesse, D., Cuvelier, L., Deprez, T., Ryck, M. D., & Schiffmann, S. N. (2010) · Brain Research · doi:10.1016/j.brainres.2010.09.063 · Cited by 54 · see citing works

Expression of SV2 isoforms during rodent brain development

Crèvecœur, J., Foerch, P., Doupagne, M., Thielen, C., Vandenplas, C., Moonen, G., Deprez, M., & Rogister, B. (2013) · BMC Neuroscience · doi:10.1186/1471-2202-14-87 · Cited by 51 · see citing works

Structural MRI detects progressive regional brain atrophy and neuroprotective effects in N171-82Q Huntington's disease mouse model

Cheng, Y., Peng, Q., Hou, Z., Aggarwal, M., Zhang, J., Mori, S., Ross, C. A., & Duan, W. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.02.022 · Cited by 50 · see citing works

Allosteric activation of M 4 muscarinic receptors improve behavioral and physiological alterations in early symptomatic YAC128 mice

Pancani, T., Foster, D. J., Moehle, M. S., Bichell, T. J., Bradley, E. M., Bridges, T. M., Klar, R., Poslusney, M., Rook, J. M., Daniels, J. S., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1512812112 · Cited by 49 · see citing works

Dysregulation of Corticostriatal Connectivity in Huntington’s Disease: A Role for Dopamine Modulation

Rangel‐Barajas, C., & Rebec, G. V. (2016) · Journal of Huntington s Disease · doi:10.3233/jhd-160221 · Cited by 49 · see citing works

Epigenetic Mechanisms Involved in Huntington's Disease Pathogenesis

Glajch, K. E., & Sadri‐Vakili, G. (2015) · Journal of Huntington s Disease · doi:10.3233/jhd-140134 · Cited by 47 · see citing works

Upcoming Meetings Related to Huntington's Disease

Glajch, K. E., & Sadri‐Vakili, G. (2015) · Journal of Huntington s Disease · doi:10.3233/jhd-159001 · Cited by 45 · see citing works

Identification of the synaptic vesicle glycoprotein 2 receptor binding site in botulinum neurotoxin A

Strotmeier, J., Mahrhold, S., Krez, N., Janzen, C., Lou, J., Marks, J. D., Binz, T., & Rummel, A. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.02.034 · Cited by 43 · see citing works

Striatal Synaptic Dysfunction and Hippocampal Plasticity Deficits in the Hu97/18 Mouse Model of Huntington Disease

Kołodziejczyk, K., Parsons, M. P., Southwell, A. L., Hayden, M. R., & Raymond, L. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094562 · Cited by 39 · see citing works

Depletion of rabphilin 3A in a transgenic mouse model (R6/1) of Huntington's disease, a possible culprit in synaptic dysfunction

Smith, R. A., Petersén, Å., Bates, G. P., Brundin, P., & Li, J. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.05.008 · Cited by 38 · see citing works

A role for Sv2c in basal ganglia functions

Dardou, D., Monlezun, S., Foerch, P., Courade, J., Cuvelier, L., Ryck, M. D., & Schiffmann, S. N. (2013) · Brain Research · doi:10.1016/j.brainres.2013.02.041 · Cited by 38 · see citing works

Influence of Genetic, Biological and Pharmacological Factors on Levodopa Dose in Parkinson’s Disease

Altmann, V., Schuh, A. F. S., Rieck, M., Callegari-Jacques, S. M., Rieder, C. R. D. M., & Hutz, M. H. (2016) · Pharmacogenomics · doi:10.2217/pgs.15.183 · Cited by 37 · see citing works

Cognitive dysfunction in H untington's disease: mechanisms and therapeutic strategies beyond BDNF

Puigdellívol, M., Saavedra, A., & Pérez‐Navarro, E. (2016) · Brain Pathology · doi:10.1111/bpa.12432 · Cited by 37 · see citing works

Altered Sensory Experience Exacerbates Stable Dendritic Spine and Synapse Loss in a Mouse Model of Huntington's Disease

Nielsen, R. M., Li, W., Szepesi, Z., & Li, J. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0244-14.2015 · Cited by 35 · see citing works

Early dysfunction and progressive degeneration of the subthalamic nucleus in mouse models of Huntington's disease

Atherton, J. F., McIver, E. L., Mullen, M. R., Wokosin, D. L., Surmeier, D. J., & Bevan, M. D. (2016) · eLife · doi:10.7554/elife.21616 · Cited by 34 · see citing works

Drug targeting of dysregulated transcription in Huntington's disease

Kazantsev, A. G., & Hersch, S. M. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.02.005 · Cited by 33 · see citing works

Impaired development of cortico-striatal synaptic connectivity in a cell culture model of Huntington's disease

Buren, C., Parsons, M. P., Smith-Dijak, A., & Raymond, L. A. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.12.009 · Cited by 33 · see citing works

Prostaglandin E2 EP2 activation reduces memory decline in R6/1 mouse model of Huntington's disease by the induction of BDNF-dependent synaptic plasticity

Anglada‐Huguet, M., Vidal-Sancho, L., Giralt, A., Barriga, G. G.-D., Xifró, X., & Alberch, J. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.09.001 · Cited by 32 · see citing works

N-type Ca2+ channels are affected by full-length mutant huntingtin expression in a mouse model of Huntington's disease

da Silva, F. R., Santos‐Miranda, A., Santos, R. P. M., Olmo, I. G., Zamponi, G. W., Dobránsky, T., Cruz, J. S., Vieira, L. B., & Ribeiro, F. M. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.03.015 · Cited by 30 · see citing works

Presynaptic dysfunction in Huntington's disease

Rozas, J. L., Gómez‐Sánchez, L., Tomás‐Zapico, C., Lucas, J. J., & Fernández‐Chacón, R. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380488 · Cited by 29 · see citing works

Control of Huntington’s Disease-Associated Phenotypes by the Striatum-Enriched Transcription Factor Foxp2

Hachigian, L. J., Carmona, V., Fenster, R. J., Kulicke, R., Heilbut, A. M., Sittler, A., de Almeida, L. P., Mesirov, J. P., Gao, F., Kolaczyk, E. D., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.018 · Cited by 27 · see citing works

The dynamics of early-state transcriptional changes and aggregate formation in a Huntington’s disease cell model

van Hagen, M., Piebes, D. G. E., de Leeuw, W. C., Vuist, I. M., van Roon‐Mom, W., Moerland, P. D., & Verschure, P. J. (2017) · BMC Genomics · doi:10.1186/s12864-017-3745-z · Cited by 26 · see citing works

Interaction between basal ganglia and limbic circuits in learning and memory processes

Calabresi, P., Picconi, B., Tozzi, A., & Ghiglieri, V. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.09.017 · Cited by 25 · see citing works

Huntington's Disease: Looking Beyond the Movement Disorder

Morreale, M. K. (2015) · Advances in psychosomatic medicine · doi:10.1159/000369111 · Cited by 23 · see citing works

YAC128 Huntington׳s disease transgenic mice show enhanced short-term hippocampal synaptic plasticity early in the course of the disease

Ghilan, M., Bostrom, C. A., Hryciw, B. N., Simpson, J. M., Christie, B. R., & Gil‐Mohapel, J. (2014) · Brain Research · doi:10.1016/j.brainres.2014.06.011 · Cited by 23 · see citing works

Viral vector-based tools advance knowledge of basal ganglia anatomy and physiology

Sizemore, R. J., Seeger-Armbruster, S., Hughes, S. M., & Parr‐Brownlie, L. C. (2016) · Journal of Neurophysiology · doi:10.1152/jn.01131.2015 · Cited by 23 · see citing works

Early GABAergic transmission defects in the external globus pallidus and rest/activity rhythm alteration in a mouse model of Huntington’s disease

Du, Z., Chazalon, M., Bestaven, E., Lesté-Lasserre, T., Baufreton, J., Cazalets, J., Cho, Y. H., & Garret, M. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.05.027 · Cited by 23 · see citing works

Immunochemical analysis of the expression of SV2C in mouse, macaque and human brain

Dunn, A. R., Hoffman, C. A., Stout, K. A., Ozawa, M., Dhamsania, R. K., & Miller, G. W. (2017) · Brain Research · doi:10.1016/j.brainres.2017.12.029 · Cited by 23 · see citing works

Genotypic variation in the SV2C gene impacts response to atypical antipsychotics the CATIE Study

Ramsey, T. L., Liu, Q., Massey, B. W., & Brennan, M. D. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.07.008 · Cited by 22 · see citing works

SMAD transcription factors are altered in cell models of HD and regulate HTT expression

Bowles, K. R., Stone, T., Holmans, P., Allen, N., Dunnett, S., & Jones, L. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2016.12.005 · Cited by 20 · see citing works

Molecular dynamics simulations of wild type and mutants of botulinum neurotoxin A complexed with synaptic vesicle protein 2C

Wang, F., Wan, H., Hu, J., & Chang, S. (2014) · Molecular BioSystems · doi:10.1039/c4mb00383g · Cited by 17 · see citing works

Dysregulation of gene expression in the striatum of BACHD rats expressing full-length mutant huntingtin and associated abnormalities on molecular and protein levels

Yu-Taeger, L., von Bonin, M., Stricker-Shaver, J., Rieß, O., & Nguyen, H. P. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.01.029 · Cited by 17 · see citing works

Demonstration of disturbed activity of external globus pallidus projecting neurons in depressed patients by the AgNOR staining method

Gos, T., Krell, D., Bielau, H., Steiner, J. H., Trübner, K., Brisch, R., Bernstein, H., Jankowski, Z., & Bogerts, B. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.03.010 · Cited by 15 · see citing works

Selective Expression of Huntingtin-associated Protein 1 in β-Cells of the Rat Pancreatic Islets

Liao, M., Chen, X.-X., Han, J., Yang, S., Peng, T., & He, L. (2009) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.2009.954479 · Cited by 13 · see citing works

Development of Research on Huntington Disease in China

Li, H., Zhang, Y., & Wu, Z. (2016) · Neuroscience Bulletin · doi:10.1007/s12264-016-0093-y · Cited by 11 · see citing works

Changes in Dopamine Signalling Do Not Underlie Aberrant Hippocampal Plasticity in a Mouse Model of Huntington’s Disease

Dallérac, G. M., Cummings, D. M., Hirst, M. C., Milnerwood, A. J., & Murphy, K. (2016) · NeuroMolecular Medicine · doi:10.1007/s12017-016-8384-z · Cited by 4 · see citing works

The Synaptic Vesicle Glycoprotein 2: Structure, Function, and Disease Relevance

Stout, K. A., Dunn, A. R., Hoffman, C., & Miller, G. W. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00351 · Cited by 112 · see citing works

Botulinum toxin blocks mast cells and prevents rosacea like inflammation

Choi, J. E., Werbel, T., Wang, Z., Wu, C. C., Yaksh, T. L., & Nardo, A. D. (2018) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2018.12.004 · Cited by 105 · see citing works

Synaptic Vesicle Protein 2: a multi-faceted regulator of secretion

Ciruelas, K., Marcotulli, D., & Bajjalieh, S. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.02.003 · Cited by 48 · see citing works

Disposition of Proteins and Lipids in Synaptic Membrane Compartments Is Altered in Q175/Q7 Huntington’s Disease Mouse Striatum

Iuliano, M., Seeley, C., Sapp, E., Jones, E. L., Martin, C., Li, X., DiFiglia, M., & Kegel-Gleason, K. B. (2021) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2021.618391 · Cited by 21 · see citing works

Blood brain barrier inflammation and potential therapeutic role of phytochemicals

Welcome, M. O. (2020) · PharmaNutrition · doi:10.1016/j.phanu.2020.100177 · Cited by 22 · see citing works

Mild cognitive impairment in Huntington’s disease: challenges and outlooks

Jellinger, K. A. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02744-8 · Cited by 19 · see citing works

Traversing the epigenetic landscape: DNA methylation from retina to brain in development and disease

Xu, C., Fu, X.-Y., Qin, H., & Yao, K. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1499719 · Cited by 17 · see citing works

Present and future use of exosomes containing proteins and RNAs in neurodegenerative diseases for synaptic function regulation: A comprehensive review

Liu, Z., Cheng, L., Cao, W., Shen, C., Qiu, Y., Li, C., Xiong, Y., Yang, S., Chen, Z., Yin, X., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.135826 · Cited by 13 · see citing works

Do Changes in Synaptic Autophagy Underlie the Cognitive Impairments in Huntington’s Disease?

Jasutkar, H. G., & Yamamoto, A. (2021) · Journal of Huntington s Disease · doi:10.3233/jhd-200466 · Cited by 10 · see citing works

Identification of SV2C and DENR as Key Biomarkers for Parkinson’s Disease Based on Bioinformatics, Machine Learning, and Experimental Verification

Wu, J., Wu, W., Jiang, P., Xu, Y., & Yu, M. (2024) · Journal of Molecular Neuroscience · doi:10.1007/s12031-023-02182-3 · Cited by 10 · see citing works

Differentiation of two human neuroblastoma cell lines alters SV2 expression patterns

Lekholm, E., Ceder, M. M., Forsberg, E. C., Schiöth, H. B., & Fredriksson, R. (2021) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-020-00243-8 · Cited by 6 · see citing works

GEM-TPC Trackers for the Super-FRS at FAIR

Kalliokoski, M., García, F., Janík, R., Lauhakangas, R., Numminen, A., Pikna, M., Sitár, B., Strmeň, P., Szarka, I., & Tuominen, E. (2010) · Lancaster EPrints (Lancaster University) · doi:10.18429/jacow-ipac2010-mopd082 · Cited by 3 · see citing works

The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases

Danna, R., Kondle, S., Amar, O., Mabourakh, M., Chen, G., Fadol, W. B., & Mohieldin, A. M. (2025) · Biology · doi:10.3390/biology14121787 · Cited by 2 · see citing works

Neuron-recognizable characteristics of peptides recombined using a neuronal binding domain of botulinum neurotoxin

Kim, H. R., Jung, Y., Shin, J., Park, M., Kweon, D., & Ban, C. (2022) · Scientific Reports · doi:10.1038/s41598-022-09145-5 · Cited by 2 · see citing works

Using Huntingtin Knock-In Minipigs to Fill the Gap Between Mouse Models and Patients with Huntington’s Disease

Liu, X., Peng, T., & Li, H. (2018) · Neuroscience Bulletin · doi:10.1007/s12264-018-0272-0

Molecular insights into anticonvulsant and botulinum neurotoxin binding of synaptic vesicle glycoprotein 2

Kammerer, R. A., & Korkhov, V. M. (2025) · Trends in Neurosciences · doi:10.1016/j.tins.2025.10.003

Synaptic dysfunction in Huntington's disease: a new perspective

Smith, R., Brundin, P., & Li, J.-Y. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5084-5 · Cited by 166 · see citing works

Abnormal association of mutant huntingtin with synaptic vesicles inhibits glutamate release

Li, H. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg218 · Cited by 136 · see citing works

N-type Ca2+ channels are affected by full-length mutant huntingtin expression in a mouse model of Huntington's disease

da Silva, F. R., Santos‐Miranda, A., Santos, R. P. M., Olmo, I. G., Zamponi, G. W., Dobránsky, T., Cruz, J. S., Vieira, L. B., & Ribeiro, F. M. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.03.015 · Cited by 30 · see citing works

Presynaptic dysfunction in Huntington's disease

Rozas, J. L., Gómez‐Sánchez, L., Tomás‐Zapico, C., Lucas, J. J., & Fernández‐Chacón, R. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380488 · Cited by 29 · see citing works

Synaptic and functional alterations in the development of mutant huntingtin expressing hiPSC‐derived neurons

Dinamarca, M. C., Colombo, L., Tousiaki, N. E., Müller, M. M., & Pecho‐Vrieseling, E. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.916019 · Cited by 4 · see citing works